FdaApplication
NDA 206352
Identifiers
- fda_app_no: NDA206352
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2014-06-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REYATAZ | ATAZANAVIR SULFATE | EQ 50MG BASE/PACKET | POWDER;ORAL |
1 product